Atherotech: Difference between revisions
Jump to navigation
Jump to search
mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
'''Atherotech, Inc.''' is a [[Birmingham]]-based | '''Atherotech, Inc.''' is a [[Birmingham]]-based cardio-diagnostic company. The company's headquarters are at 201 [[London Parkway]] off of [[Lakeshore Parkway]] in [[Oxmoor Valley]]. | ||
The company developed and sells a cholesterol test called the VAP Test, based on Vertical Auto Profile Technology developed by [[UAB]] physician and professor [[Jere Segrest]]. | The company developed and sells a cholesterol test called the VAP Test, based on Vertical Auto Profile Technology developed by [[UAB]] physician and professor [[Jere Segrest]]. | ||
In January [[2009]], [[Mike Mullen]] was named Athereotech's president. | In January [[2009]], [[Mike Mullen]] was named Athereotech's president. The company was bought by Behrman Capital, a New York-based investment firm, on [[December 23]], [[2010]]. | ||
{{stub}} | {{stub}} | ||
==References== | ==References== | ||
*Tomberlin, Michael (January 7, 2008) "Birmingham's Atherotech names news president, other execs." ''Birmingham News'' | * Tomberlin, Michael (January 7, 2008) "Birmingham's Atherotech names news president, other execs." ''Birmingham News'' | ||
* Diel, Stan (January 13, 2011) "Atherotech acquired by New York investment firm." ''Birmingham News'' | |||
==External links== | ==External links== | ||
*[http://www.atherotech.com/ Atherotech] website | * [http://www.atherotech.com/ Atherotech] website | ||
[[Category:London Parkway]] | [[Category:London Parkway]] | ||
[[Category:UAB research]] | [[Category:UAB research]] | ||
Revision as of 12:47, 13 January 2011
Atherotech, Inc. is a Birmingham-based cardio-diagnostic company. The company's headquarters are at 201 London Parkway off of Lakeshore Parkway in Oxmoor Valley.
The company developed and sells a cholesterol test called the VAP Test, based on Vertical Auto Profile Technology developed by UAB physician and professor Jere Segrest.
In January 2009, Mike Mullen was named Athereotech's president. The company was bought by Behrman Capital, a New York-based investment firm, on December 23, 2010.
References
- Tomberlin, Michael (January 7, 2008) "Birmingham's Atherotech names news president, other execs." Birmingham News
- Diel, Stan (January 13, 2011) "Atherotech acquired by New York investment firm." Birmingham News
External links
- Atherotech website